[Federal Register Volume 67, Number 75 (Thursday, April 18, 2002)]
[Notices]
[Page 19195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-9423]



[[Page 19195]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussion could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: May 28, 2002.
    Open: 8 a.m. to 2:15 p.m.
    Agenda: The agenda includes the Opening Remarks by Director, 
NCCAM, Reports on NCCAM Communications and Outreach, CAPCAM Report, 
Hypericum Study Results, Final IHR Plan, Final MHHD Plan, and other 
business of the Council.
    Closed: 2:15 p.m. to adjournment.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: Neuroscience Conference Center, 6001 Executive Boulevard, 
Rockville, MD 20852.
    Contact Person: Jane F. Kinsel, PhD., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892. 301/402-7269.
    The public comments session is scheduled from 12-12:30 pm. Each 
speaker will be permitted 5 minutes for their presentation. 
Interested individuals and representatives of organizations are 
requested to notify Dr. Jane Kinsel, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland, 20892, 301-402-7269, Fax: 
301-480-3519. Letters of intent to present comments, along with a 
brief description of the organization represented, should be 
received no later than 5 p.m. on May 17, 2002. Only one 
representative of an organization may present oral comments. Any 
person attending the meeting who does not request an opportunity to 
speak in advance of the meeting may be considered for oral 
presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. 
Jane Kinsel at the address listed above up to ten calendar days 
(June 7, 2002) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by Dr. Jane Kinsel, Executive Secretary, 
NACCAM, National Institutes of Health, 6707 Democracy Boulevard, 
Suite 401, Bethesda, Maryland 20892, 301-402-7269, Fax 301-480-3519.

    Dated: April 11, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 02-9423 Filed 4-17-02; 8:45 am]
BILLING CODE 4140-01-M